In silico screening of potential FGF2 inhibitors for cancer therapy
Crossref DOI link: https://doi.org/10.1007/s40203-025-00495-2
Published Online: 2025-11-26
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Senrung, Anna
Text and Data Mining valid from 2025-11-26
Version of Record valid from 2025-11-26
Article History
Received: 10 December 2024
Accepted: 7 November 2025
First Online: 26 November 2025
Declarations
:
: There is no competing or conflict of interest from any party.